normal VIII-related protein, as described by Holmberg and Nilsson (1973). The three patients to whom cryo-precipitate was given all showed a post-infusion correction of Ristocetin aggre-gation, although the response of factor VIII and VIII-related protein varied in each case. To the standard definition of classical von Willebrand's disease, it is now possible to add abnormal Ristocetin-induced aggregation and reduced or absent levels of factor-VIII-related protein. However, more variants of this disorder, two of which have been discussed in this paper, are likely to be described
Botrocetin, originally called venom coagglutinin, is a Bothrops factor that causes aggregation of bl...
Until the mid-80s, cryoprecipitate has been the mainstay of treatment of patients with von Willebran...
(vWD) and pseudo-vWD are two recently described intrinsic platelet defects characterized by enhanced...
We have studied a patient with von Willebrand's disease (vWd) whose von Willebrand factor (vWf) mult...
tor protein was characterized in two unrelated patients with von Willebrand's disease in whom p...
We studied four patients who showed aggregation of platelets in platelet-rich plasma at lower concen...
In this study a new variant of type II von Willebrand disease is identified by multimeric analyses o...
SUMMARY This report describes a patient without evident underlying disease, in whom an acquired von ...
Until the mid 1980s, cryoprecipitate had been the mainstay of treatment of patients with von Willebr...
A new type II variant form of von Willebrand’s disease has been recognized in a mother and daughter ...
Factor VIII von Willebrand may be detected by a Ristocetin-dependent platelet agglutination reaction...
The recovery of factor VIII-activity in cryoprecipitate prepared from plasma from six patients with ...
Insolubilized rabbit antifactor VIII sera removed factor VIII activity and factor VIII related antig...
It is generally held that factor VIII (FVIII) does not increase in the plasma of severe von Willebra...
Factor VIIII (FVIII) and von Willebrand factor (VWF) are two distinct but related glycoproteins that...
Botrocetin, originally called venom coagglutinin, is a Bothrops factor that causes aggregation of bl...
Until the mid-80s, cryoprecipitate has been the mainstay of treatment of patients with von Willebran...
(vWD) and pseudo-vWD are two recently described intrinsic platelet defects characterized by enhanced...
We have studied a patient with von Willebrand's disease (vWd) whose von Willebrand factor (vWf) mult...
tor protein was characterized in two unrelated patients with von Willebrand's disease in whom p...
We studied four patients who showed aggregation of platelets in platelet-rich plasma at lower concen...
In this study a new variant of type II von Willebrand disease is identified by multimeric analyses o...
SUMMARY This report describes a patient without evident underlying disease, in whom an acquired von ...
Until the mid 1980s, cryoprecipitate had been the mainstay of treatment of patients with von Willebr...
A new type II variant form of von Willebrand’s disease has been recognized in a mother and daughter ...
Factor VIII von Willebrand may be detected by a Ristocetin-dependent platelet agglutination reaction...
The recovery of factor VIII-activity in cryoprecipitate prepared from plasma from six patients with ...
Insolubilized rabbit antifactor VIII sera removed factor VIII activity and factor VIII related antig...
It is generally held that factor VIII (FVIII) does not increase in the plasma of severe von Willebra...
Factor VIIII (FVIII) and von Willebrand factor (VWF) are two distinct but related glycoproteins that...
Botrocetin, originally called venom coagglutinin, is a Bothrops factor that causes aggregation of bl...
Until the mid-80s, cryoprecipitate has been the mainstay of treatment of patients with von Willebran...
(vWD) and pseudo-vWD are two recently described intrinsic platelet defects characterized by enhanced...